Skip to content
  • Sunday, 23 August 2026
  • 7:55 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Existing Chronic Constipation Medication Demonstrates Significant Potential to Alleviate Lingering Cognitive Deficits in Post-Depression Recovery
Neuroscience & Brain Research

Existing Chronic Constipation Medication Demonstrates Significant Potential to Alleviate Lingering Cognitive Deficits in Post-Depression Recovery

Rifan Muazin Jul 16, 2026 0

While the clinical treatment of major depressive disorder has historically focused on stabilizing mood and emotional regulation, a significant portion…

Read More
Biotech & Genetic Research

GLP-1R Weight Loss Drugs May Alleviate Depression Through Gut Microbiome-Endocannabinoid-Brain Axis

Jia Lissa Jul 7, 2026 0

Emerging evidence has consistently suggested that glucagon-like peptide-1 receptor (GLP-1R) weight loss drugs, initially developed for metabolic conditions, may offer…

Read More
Clinical Laboratories Bolster National Disease Surveillance Amidst Temporary CDC Testing HaltThe U.S. Botanic Garden wants you to stop and smell America’s state flowers.Nature’s Molecular Velcro Offers Blueprint for Supercharged CropsVisualizing Patterns in Solutions: How Dataset Shape Dictates Your Coding Style
Japan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ